A Hat Trick Of Cell And Gene Therapy IPOs: AVRO, MGTA, and UMRX

Last week, AvroBio and Magenta Therapeutics priced their IPOs on the same night. Less than three months earlier, Unum Therapeutics priced its IPO. All three are cell and gene therapy biotechs. The author shares his reflections on those companies, the markets, and the cell & gene therapy space

Read the full post on Forbes - Pharma & Healthcare